{
    "clinical_study": {
        "@rank": "308",
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on April 14, 2020",
            "link_text": "Link to the current ClinicalTrials.gov record.",
            "url": "https://clinicaltrials.gov/show/NCT04340466"
        },
        "id_info": {
            "org_study_id": "2020-A00797-32",
            "nct_id": "NCT04340466"
        },
        "brief_title": "French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study",
        "acronym": "FRENCH CORONA",
        "official_title": "French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management: the FRENCH CORONA Study",
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de N\u012bmes",
                "agency_class": "Other"
            }
        },
        "source": "Centre Hospitalier Universitaire de N\u012bmes",
        "oversight_info": {
            "has_dmc": "No",
            "is_fda_regulated_drug": "No",
            "is_fda_regulated_device": "No"
        },
        "brief_summary": {
            "textblock": "Since December 2019, a new agent, the SARS-Cov-2 coronavirus has been rapidly spreading from\n      China to other countries causing an international outbreak of respiratory illnesses named\n      COVID-19. In France, the first cases have been reported at the end of January with more than\n      60000 cases reported since then. A significant proportion (20-30%) of hospitalized COVID-19\n      patients will be admitted to intensive care unit. However, few data are available for this\n      special population in France.\n\n      We conduct a large observational cohort of ICU suspected or proven COVID-19 patients that\n      will enable to describe the initial management of COVID 19 patients admitted to ICU and to\n      identify factors correlated to clinical outcome."
        },
        "overall_status": "Recruiting",
        "start_date": {
            "@type": "Actual",
            "#text": "April 3, 2020"
        },
        "completion_date": {
            "@type": "Anticipated",
            "#text": "April 30, 2021"
        },
        "primary_completion_date": {
            "@type": "Anticipated",
            "#text": "June 30, 2020"
        },
        "study_type": "Observational [Patient Registry]",
        "has_expanded_access": "No",
        "study_design_info": {
            "observational_model": "Cohort",
            "time_perspective": "Prospective"
        },
        "target_duration": "28 Days",
        "primary_outcome": {
            "measure": "Mortality at day 28",
            "time_frame": "day 28",
            "description": "Mortality at day 28"
        },
        "secondary_outcome": [
            {
                "measure": "severe complications",
                "time_frame": "up to day 28",
                "description": "severe complications (pulmonary embolism, acute kidney injury, myocarditis, cardiac arrest, liver failure, ventilator associated pneumonia) Yes / No"
            },
            {
                "measure": "Imaging",
                "time_frame": "day 1",
                "description": "Delay in imaging in hours"
            },
            {
                "measure": "Delay in Microbiological diagnosis",
                "time_frame": "day 1",
                "description": "delay in microbiological diagnosis in hours"
            },
            {
                "measure": "Antiviral therapy",
                "time_frame": "up to day 28",
                "description": "Antiviral therapy Yes / no"
            },
            {
                "measure": "Antibiotic therapy",
                "time_frame": "day 28",
                "description": "Antibiotic therapy Yes / No"
            },
            {
                "measure": "Covid-19 treatments",
                "time_frame": "up to day 28",
                "description": "Covid-19 treatments Yes / No"
            },
            {
                "measure": "Patients receiving renal replacement therapy",
                "time_frame": "up to day 28",
                "description": "number"
            },
            {
                "measure": "Patients receiving mechanical ventilation",
                "time_frame": "up to day 28",
                "description": "number"
            },
            {
                "measure": "Vital status",
                "time_frame": "day 28",
                "description": "Patient alive at day 28 : yes / No"
            }
        ],
        "number_of_groups": "2",
        "enrollment": {
            "@type": "Anticipated",
            "#text": "220"
        },
        "condition": [
            "Pneumonia, Viral",
            "Critically Ill",
            "Corona Virus Infection"
        ],
        "arm_group": [
            {
                "arm_group_label": "Suspected or proven COVID-19 critically ill patients"
            },
            {
                "arm_group_label": "Control"
            }
        ],
        "intervention": {
            "intervention_type": "Other",
            "intervention_name": "No intervention",
            "description": "No intervention",
            "arm_group_label": [
                "Control",
                "Suspected or proven COVID-19 critically ill patients"
            ]
        },
        "eligibility": {
            "study_pop": {
                "textblock": "The target population of the study is all patients with suspected or proven SARS-Cov-2\n        infection (COVID-19)"
            },
            "sampling_method": "Non-Probability Sample",
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients admitted to ICU for suspected or proven SARS-Cov-2 infection, defined by\n             positive SARS-Cov-2 PCR or CT scan images\n\n          -  Patient > or= 18 years\n\n        Exclusion Criteria:\n\n          -  Patient study refusal\n\n          -  Patient already enrolled in the present study\n\n          -  Patient with respiratory illness with negative COVID-19 CT scan images and negative\n             COVID_19 PCR"
            },
            "gender": "All",
            "minimum_age": "18 Years",
            "maximum_age": "N/A",
            "healthy_volunteers": "No"
        },
        "overall_official": {
            "last_name": "CLAIRE ROGER",
            "role": "Principal Investigator",
            "affiliation": "Nimes University Hospital"
        },
        "overall_contact": {
            "last_name": "CLAIRE ROGER, MD, PhD",
            "phone": "0033466683050",
            "email": "claire.roger@chu-nimes.fr"
        },
        "overall_contact_backup": {
            "last_name": "Anissa MEGZARI",
            "email": "drc@chu-nimes.fr"
        },
        "location": {
            "facility": {
                "name": "CHU Nimes",
                "address": {
                    "city": "N\u00eemes",
                    "zip": "30029",
                    "country": "France"
                }
            },
            "status": "Recruiting",
            "contact": {
                "last_name": "Claire Roger, MD, PhD",
                "phone": "+33466683331",
                "email": "claire.roger@chu-nimes.fr"
            }
        },
        "location_countries": {
            "country": "France"
        },
        "verification_date": "April 2020",
        "study_first_submitted": "April 7, 2020",
        "study_first_submitted_qc": "April 7, 2020",
        "study_first_posted": {
            "@type": "Actual",
            "#text": "April 9, 2020"
        },
        "last_update_submitted": "April 10, 2020",
        "last_update_submitted_qc": "April 10, 2020",
        "last_update_posted": {
            "@type": "Estimate",
            "#text": "April 14, 2020"
        },
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        },
        "keyword": [
            "COVID-19",
            "SARS-Cov-2",
            "Intensive Care Unit"
        ],
        "condition_browse": {
            "mesh_term": [
                "Infection",
                "Communicable Diseases",
                "Coronavirus Infections",
                "Severe Acute Respiratory Syndrome",
                "Pneumonia, Viral",
                "Pneumonia",
                "Critical Illness",
                "Virus Diseases"
            ]
        },
        "patient_data": {
            "sharing_ipd": "No"
        }
    }
}